Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Crutial 450 day data.

<< Previous

Bullboard Posts

Next >>

Comment by greaterfoolFredon Nov 13, 2022 5:00pm

191 Views

Post# 35095289

RE:RE:RE:RE:RE:Crutial 450 day data.

Yes, nice numbers wildbird, but I dont think you can just drop the 5 NRs from the undertreated 12. Any trial would work out with nice numbers if you could drop the NRs and just keep the CRs. If you want to drop those 5, you have to drop all 12, which is what we should do. Of course you can't just hide them from the FDA, but we should submit 25 optimized patients' data; worth the wait I think.
Just keepin it real, and good luck all.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023